Banco BTG Pactual’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,346
Closed -$449K 162
2023
Q3
$449K Buy
+4,346
New +$485K 0.11% 71
2023
Q1
Sell
-4,226
Closed -$759K 168
2022
Q4
$759K Buy
+4,226
New +$691K 0.43% 51
2022
Q2
Sell
-1,250
Closed -$215K 143
2022
Q1
$215K Buy
+1,250
New +$210K 0.07% 107
2021
Q2
Sell
-1,900
Closed -$249K 119
2021
Q1
$249K Buy
+1,900
New +$275K 0.08% 88
2020
Q3
Sell
-3,800
Closed -$244K 71
2020
Q2
$244K Sell
3,800
-11,200
-75% -$613K 0.1% 42
2020
Q1
$449K Buy
+15,000
New +$345K 0.47% 39

Other funds holding MRNA

Banco BTG Pactual's MRNA Position: Q4 2023 in Review

Banco BTG Pactual sold out of Moderna (MRNA) in Q4 2023, closing a stake of 4,346 shares — an estimated $449K sold.

Banco BTG Pactual first reported a position in MRNA in Q1 2020 and held it in 6 quarters. The position peaked at $759K in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Banco BTG Pactual reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Banco BTG Pactual sold 4,346 Moderna shares in Q4 2023, an estimated $449K.
  • Banco BTG Pactual first reported a position in Moderna in Q1 2020 and held it in 6 quarters.
  • Banco BTG Pactual's Moderna position peaked at $759K in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Banco BTG Pactual's 13F filing for Q4 2023, filed 12 Feb 2024.